Development and Marketing of INCIVEK (Telaprevir; VX-950): A First-Generation HCV Protease Inhibitor, in Combination with PEGylated Interferon and Ribavirin
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Kwong, Ann D.
Perni, Robert B.
Graham, Camilla S.
Text and Data Mining valid from 2019-01-01
13 June 2019